The Herald ghanaThe Herald ghana
  • Home
  • General
  • Entertainment
  • Politics
  • Editorial
  • Business
  • Sports
  • Feature
  • Health
  • World
Reading: Life-saving HIV prevention injection costs $28,000 a year
Share
Aa
The Herald ghanaThe Herald ghana
Aa
  • Home
  • General
  • Entertainment
  • Politics
  • Editorial
  • Business
  • Sports
  • Feature
  • Health
  • World
Search
  • Home
  • General
  • Entertainment
  • Politics
  • Editorial
  • Business
  • Sports
  • Feature
  • Health
  • World
Follow US
  • Advertise
Copyright © 2022 The Herald Ghana. All Rights Reserved
GeneralHealthMajor 1

Life-saving HIV prevention injection costs $28,000 a year

Published August 12, 2025 2 Min Read
Share
2 Min Read
Yeztugo/US/HIV/Gilead Sciences
SHARE

Gilead Sciences has secured approval from the United States health authorities for its new HIV prevention injection, Yeztugo, but concerns are growing over its steep price tag.

The twice-yearly shot, based on the drug lenacapavir, is designed for people who struggle to take daily pills to prevent HIV. 

In major clinical trials involving thousands of adults and teenagers from diverse backgrounds, Yeztugo proved highly effective, preventing HIV in over 99.9% of participants.

Eligible for anyone weighing at least 35 kilograms, the injection could revolutionise HIV prevention for many. 

However, Gilead has set the annual price in the US at more than US$28,000, prompting fears that only the wealthy will have access in high-income countries.

More Read

US revokes more than 6,000 visas in birth tourism crackdown

Mahama urges US to address gun violence after Ghanaian teenager’s killing
Ghana eyes value-added exports to cushion impact of possible AGOA exit
Ghana scholarship beneficiaries abroad face mandatory oath, repayment obligations

Health experts note that a generic version could cost as little as US$25 per year if produced at scale. This stark difference has intensified debate about affordability and equity.

To address accessibility in low- and middle-income nations, Gilead has partnered with six manufacturers to produce cheaper versions. 

These agreements cover 120 countries and include a pledge to supply doses for two million people through global health partnerships. Still, these low-cost alternatives require regulatory approval and may take years to reach patients.

While the approval of Yeztugo marks a significant advance in HIV prevention, the high cost and slow rollout of cheaper versions could limit its global impact. 

For many health advocates, the question remains whether life-saving prevention will be a privilege or a right.

Source: Graphic Online

You Might Also Like

US revokes more than 6,000 visas in birth tourism crackdown

Mahama urges US to address gun violence after Ghanaian teenager’s killing

Ghana eyes value-added exports to cushion impact of possible AGOA exit

Ghana scholarship beneficiaries abroad face mandatory oath, repayment obligations

ab.teye August 12, 2025
Share this Article
Facebook Twitter Whatsapp Whatsapp Copy Link
What do you think?
Love0
Sad0
Cry0
Happy0
Surprise0
Angry0
Wink0
Previous Article Atuabo Gas /Shut Down/Maintenance Atuabo Gas Plant faces 14-day shutdown as govt races to protect power supply
Next Article Taylor Swift/The Life of a Showgirl/Travis Kelce Taylor Swift announces new album, The Life of a Showgirl

Stay Connected

Facebook Like
Twitter Follow
Instagram Follow
Youtube Subscribe
- Advertisement -
Ad imageAd image

Latest News

Netherlands, Ghana deepen economic ties to boost self-sufficiency
General Major 2 November 19, 2026
court hammer/coup/marriage
Court of Appeal upholds life sentence for Jirapa Dubai hotel murder convict
General Major 4 November 19, 2026
Tottenham man arrested in Dublin over fatal stabbing of 21-year-old in North London
General Major 2 November 19, 2026
Emirates tops Time’s inaugural World’s Best Airlines 2027 rankings
Business Major 2 November 19, 2026
CurrencyRate

You Might also Like

GeneralMajor 3

US revokes more than 6,000 visas in birth tourism crackdown

November 16, 2026
GeneralMajor 2

Mahama urges US to address gun violence after Ghanaian teenager’s killing

November 5, 2026
AfCFTA/Export
BusinessMajor 2

Ghana eyes value-added exports to cushion impact of possible AGOA exit

November 3, 2026
Civil Society Organizations (CSOs)/Ghana Scholarships Authority Bill/Parliament
GeneralMajor 4

Ghana scholarship beneficiaries abroad face mandatory oath, repayment obligations

October 1, 2026
Show More

Copyright © 2022-2025 The Herald Ghana. All Rights Reserved

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?